世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 Specialty Picture Archiving And Communication System Market Size, Share & Trends Analysis Report By Specialty (Radiology PACS, Pathology PACS), By Deployment Mode (Cloud-based/Web-based, Hybrid), By End Use (Hospitals, Diagnostic Imaging Centers), By Region, And Segment Forecasts, 2025 - 2033
Specialty PACS Market Summary The global specialty picture archiving and communication system market size was estimated at USD 3.74 billion in 2024 and is projected to reach USD 6.57 billion by... もっと見る
英語原文をAIを使って翻訳しています。
SummarySpecialty PACS Market SummaryThe global specialty picture archiving and communication system market size was estimated at USD 3.74 billion in 2024 and is projected to reach USD 6.57 billion by 2033, growing at a CAGR of 6.6% from 2025 to 2033. This growth is attributed to rising adoption of digital imaging solutions, the increasing volume of medical imaging procedures, growing demand for tele radiology and remote diagnostics, Government initiatives and regulatory support for healthcare IT adoption, and Technological advancements in cloud-based PACS solutions. Moreover, the growing integration of artificial intelligence (AI) into specialty PACS is an emerging trend shaping the market. The increasing volume of medical imaging procedures is a major driver for the specialty (Picture Archiving And Communication System) PACS industry. The growth is fueled by the rising prevalence of chronic diseases, an aging population, and advances in imaging modalities that expand diagnostic capabilities. As more scans are performed across specialties such as cardiology, mammography, orthopedics, and dentistry, healthcare providers face growing challenges in storing, retrieving, and managing large volumes of complex image data. According to the Journal of the American College of Radiology, imaging utilization is projected to rise from 16.9% in 2023 to 26.9% by 2055, highlighting the accelerating demand for efficient imaging management systems which further emphasizes the need for specialty PACS solutions that offer tailored workflows, advanced visualization, and streamlined data management to enable faster interpretation, improved collaboration, and better patient outcomes. Rising adoption of tele radiology is driving growth in the specialty PACS market, as healthcare providers increasingly rely on remote diagnostic services to address radiologist shortages, expand access to expertise, and enable around-the-clock reporting. According to Merative, by 2033, the U.S. could face a shortage of up to 42,000 radiologists. Tele radiology allows medical images from modalities such as CT, MRI, mammography, and ultrasound to be shared instantly across locations, supporting faster diagnoses and continuity of care, particularly in rural or underserved regions. Specialty PACS solutions complement this demand by offering cloud-based access, secure image sharing, and specialty-specific workflows that ensure seamless collaboration between radiologists and referring physicians across geographies, improving efficiency, turnaround times, and diagnostic accuracy. Global Specialty PACS Market Report Segmentation This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global specialty PACS market report based on specialty, deployment mode, end use, and region: • Specialty Outlook (Revenue, USD Million, 2021 - 2033) • Radiology PACS • Cardiology PACS • Mammography PACS • Orthopedic PACS • Ophthalmology PACS • Pathology PACS • Oncology / Radiation Therapy PACS • Others • Deployment Mode Outlook (Revenue, USD Million, 2021 - 2033) • Cloud-Based/ Web-Based • On-premise • Hybrid • End Use Outlook (Revenue, USD Million, 2021 - 2033) • Hospitals • Specialty Clinics • Diagnostic Imaging Centers • Telemedicine & Tele radiology Providers • Others • Regional Outlook (Revenue, USD Million, 2021 - 2033) • North America o U.S. o Canada o Mexico • Europe o UK o Germany o France o Italy o Spain o Denmark o Sweden o Norway • Asia Pacific o China o Japan o India o South Korea o Australia o Thailand • Latin America o Brazil o Argentina • Middle East and Africa (MEA) o South Africa o Saudi Arabia o UAE o Kuwait Table of ContentsTable of ContentsChapter 1. Methodology and Scope 1.1. Market Segmentation & Scope 1.2. Segment Definitions 1.2.1. Specialty 1.2.2. Deployment Mode 1.2.3. End use 1.3. Estimates and Forecast Timeline 1.4. Research Methodology 1.5. Information Procurement 1.5.1. Purchased Database 1.5.2. GVR’s Internal Database 1.5.3. Secondary Sources 1.5.4. Primary Research 1.6. Information Analysis 1.6.1. Data Analysis Models 1.7. Market Formulation & Data Visualization 1.8. Model Details 1.8.1. Commodity Flow Analysis 1.9. List of Secondary Sources 1.10. Objectives Chapter 2. Executive Summary 2.1. Market Snapshot 2.2. Segment Snapshot 2.3. Competitive Landscape Snapshot Chapter 3. Market Variables, Trends, & Scope 3.1. Market Lineage Outlook 3.2. Market Dynamics 3.2.1. Market Driver Analysis 3.2.1.1. Rising adoption of digital imaging solutions 3.2.1.2. Increasing volume of medical imaging procedures 3.2.1.3. Expanding remote access and telemedicine adoption 3.2.1.4. Growing demand for specialty-specific imaging 3.2.1.5. Increasing integration with EHR/EMR and RIS systems 3.2.2. Market Restraint Analysis 3.2.2.1. High implementation and maintenance costs 3.2.2.2. Data privacy and security concerns 3.2.2.3. Limited availability of skilled workforce to operate and manage PACS 3.2.2.4. Complex and varying regulatory requirements across regions 3.2.3. Industry Opportunity Analysis 3.2.4. Industry Challenge Analysis 3.2.5. Technology Overview 3.2.5.1. AI & Machine Learning 3.2.5.2. 3D Visualization & Reconstruction 3.2.5.3. Automated Workflow & Reporting Tools 3.2.5.4. Cloud Storage & Remote Access 3.2.6. Company-Level Security & Compliance Overview 3.2.7. Case Studies 3.3. Business Environment Analysis 3.3.1. Porter’s Five Forces Analysis 3.3.1.1. Supplier power 3.3.1.2. Buyer power 3.3.1.3. Substitution threat 3.3.1.4. Threat of new entrant 3.3.1.5. Competitive rivalry 3.3.2. PESTLE Analysis 3.3.2.1. Political landscape 3.3.2.2. Economic and Social landscape 3.3.2.3. Technological landscape 3.3.2.4. Environmental landscape 3.3.2.5. Legal Landscape Chapter 4. Specialty PACS Market: Specialty Estimates & Trend Analysis 4.1. Specialty Segment Dashboard 4.2. Specialty Market Share Movement Analysis, 2024 & 2033 4.3. Market Size & Forecasts and Trend Analysis, by Specialty, 2021 to 2033 (USD Million) 4.4. Radiology PACS 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million) 4.5. Cardiology PACS 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million) 4.6. Mammography PACS 4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million) 4.7. Orthopedic PACS 4.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million) 4.8. Ophthalmology PACS 4.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million) 4.9. Pathology PACS 4.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million) 4.10. Oncology / Radiation Therapy PACS 4.10.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million) 4.11. Others 4.11.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million) Chapter 5. Specialty PACS Market: Deployment Mode Estimates & Trend Analysis 5.1. Deployment Mode Dashboard 5.2. Deployment Mode Market Share Movement Analysis, 2024 & 2033 5.3. Market Size & Forecasts and Trend Analysis, by Deployment Mode, 2021 to 2033 (USD Million) 5.4. Cloud-Based/ Web-Based 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million) 5.5. On-Premise 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million) 5.6. Hybrid 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million) Chapter 6. Specialty PACS Market: End Use Estimates & Trend Analysis 6.1. End Use Segment Dashboard 6.2. End Use Market Share Movement Analysis, 2024 & 2033 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million) 6.4. Hospitals 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million) 6.5. Specialty Clinics 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million) 6.6. Diagnostic Imaging Centers 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million) 6.7. Telemedicine & Tele radiology Providers 6.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million) 6.8. Others 6.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million) Chapter 7. Specialty PACS Market: Regional Estimates & Trend Analysis 7.1. Regional Market Dashboard 7.2. Regional Market: Key Takeaways 7.3. North America 7.3.1. North America Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) 7.3.2. U.S. 7.3.2.1. Key country dynamics 7.3.2.2. Regulatory framework 7.3.2.3. Competitive insights 7.3.2.4. U.S. Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) 7.3.3. Canada 7.3.3.1. Key country dynamics 7.3.3.2. Regulatory framework 7.3.3.3. Competitive insights 7.3.3.4. Canada Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) 7.3.4. Mexico 7.3.4.1. Key country dynamics 7.3.4.2. Regulatory framework 7.3.4.3. Competitive insights 7.3.4.4. Mexico Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) 7.4. Europe 7.4.1. Europe Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) 7.4.2. Germany 7.4.2.1. Key country dynamics 7.4.2.2. Regulatory framework 7.4.2.3. Competitive insights 7.4.2.4. Germany Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) 7.4.3. UK 7.4.3.1. Key country dynamics 7.4.3.2. Regulatory framework 7.4.3.3. Competitive insights 7.4.3.4. UK Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) 7.4.4. France 7.4.4.1. Key country dynamics 7.4.4.2. Regulatory framework 7.4.4.3. Competitive insights 7.4.4.4. France Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) 7.4.5. Italy 7.4.5.1. Key country dynamics 7.4.5.2. Regulatory framework 7.4.5.3. Competitive insights 7.4.5.4. Italy Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) 7.4.6. Spain 7.4.6.1. Key country dynamics 7.4.6.2. Regulatory framework 7.4.6.3. Competitive insights 7.4.6.4. Spain Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) 7.4.7. Denmark 7.4.7.1. Key country dynamics 7.4.7.2. Regulatory framework 7.4.7.3. Competitive insights 7.4.7.4. Denmark Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) 7.4.8. Sweden 7.4.8.1. Key country dynamics 7.4.8.2. Regulatory framework 7.4.8.3. Competitive insights 7.4.8.4. Sweden Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) 7.4.9. Norway 7.4.9.1. Key country dynamics 7.4.9.2. Regulatory framework 7.4.9.3. Competitive insights 7.4.9.4. Norway Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) 7.5. Asia Pacific 7.5.1. Asia Pacific Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) 7.5.2. Japan 7.5.2.1. Key country dynamics 7.5.2.2. Regulatory framework 7.5.2.3. Competitive insights 7.5.2.4. Japan Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) 7.5.3. China 7.5.3.1. Key country dynamics 7.5.3.2. Regulatory framework 7.5.3.3. Competitive insights 7.5.3.4. China Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) 7.5.4. India 7.5.4.1. Key country dynamics 7.5.4.2. Regulatory framework 7.5.4.3. Competitive insights 7.5.4.4. India Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) 7.5.5. South Korea 7.5.5.1. Key country dynamics 7.5.5.2. Regulatory framework 7.5.5.3. Competitive insights 7.5.5.4. South Korea Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) 7.5.6. Australia 7.5.6.1. Key country dynamics 7.5.6.2. Regulatory framework 7.5.6.3. Competitive insights 7.5.6.4. Australia Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) 7.5.7. Thailand 7.5.7.1. Key country dynamics 7.5.7.2. Regulatory framework 7.5.7.3. Competitive insights 7.5.7.4. Thailand Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) 7.6. Latin America 7.6.1. Latin America Specialty PACS Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.6.2. Brazil 7.6.2.1. Key country dynamics 7.6.2.2. Regulatory framework 7.6.2.3. Competitive insights 7.6.2.4. Brazil Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) 7.6.3. Argentina 7.6.3.1. Key country dynamics 7.6.3.2. Regulatory framework 7.6.3.3. Competitive insights 7.6.3.4. Argentina Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) 7.7. MEA 7.7.1. MEA Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) 7.7.2. South Africa 7.7.2.1. Key country dynamics 7.7.2.2. Regulatory framework 7.7.2.3. Competitive insights 7.7.2.4. South Africa Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) 7.7.3. Saudi Arabia 7.7.3.1. Key country dynamics 7.7.3.2. Regulatory framework 7.7.3.3. Competitive insights 7.7.3.4. Saudi Arabia Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) 7.7.4. UAE 7.7.4.1. Key country dynamics 7.7.4.2. Regulatory framework 7.7.4.3. Competitive insights 7.7.4.4. UAE Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) 7.7.5. Kuwait 7.7.5.1. Key country dynamics 7.7.5.2. Regulatory framework 7.7.5.3. Competitive insights 7.7.5.4. Kuwait Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) Chapter 8. Competitive Landscape 8.1. Participant Overview 8.2. Company Market Position Analysis/Company Market Share Analysis (2024) 8.3. Company Categorization 8.4. Strategy Mapping 8.5. Company Profiles/Listing 8.5.1. Novarad 8.5.1.1. Overview 8.5.1.2. Financial performance 8.5.1.3. Product benchmarking 8.5.1.4. Strategic initiatives 8.5.2. INFINITT North America Inc. 8.5.2.1. Overview 8.5.2.2. Financial performance 8.5.2.3. Product benchmarking 8.5.2.4. Strategic initiatives 8.5.3. Sectra AB 8.5.3.1. Overview 8.5.3.2. Financial performance 8.5.3.3. Product benchmarking 8.5.3.4. Strategic initiatives 8.5.4. Intelerad 8.5.4.1. Overview 8.5.4.2. Financial performance 8.5.4.3. Product benchmarking 8.5.4.4. Strategic initiatives 8.5.5. Koninklijke Philips N.V. 8.5.5.1. Overview 8.5.5.2. Financial performance 8.5.5.3. Product benchmarking 8.5.5.4. Strategic initiatives 8.5.6. GE HealthCare 8.5.6.1. Overview 8.5.6.2. Financial performance 8.5.6.3. Product benchmarking 8.5.6.4. Strategic initiatives 8.5.7. FUJIFILM Corporation 8.5.7.1. Overview 8.5.7.2. Financial performance 8.5.7.3. Product benchmarking 8.5.7.4. Strategic initiatives 8.5.8. Canon Medical Systems, USA. 8.5.8.1. Overview 8.5.8.2. Financial performance 8.5.8.3. Product benchmarking 8.5.8.4. Strategic initiatives 8.5.9. Agfa HealthCare 8.5.9.1. Overview 8.5.9.2. Financial performance 8.5.9.3. Product benchmarking 8.5.9.4. Strategic initiatives 8.5.10. Merative 8.5.10.1. Overview 8.5.10.2. Financial performance 8.5.10.3. Product benchmarking 8.5.10.4. Strategic initiatives 8.5.11. Ramsoft 8.5.11.1. Overview 8.5.11.2. Financial performance 8.5.11.3. Product benchmarking 8.5.11.4. Strategic initiatives 8.5.12. Optum, Inc. 8.5.12.1. Overview 8.5.12.2. Financial performance 8.5.12.3. Product benchmarking 8.5.12.4. Strategic initiatives 8.5.13. Siemens Healthineers AG 8.5.13.1. Overview 8.5.13.2. Financial performance 8.5.13.3. Product benchmarking 8.5.13.4. Strategic initiatives 8.5.14. Medstrat 8.5.14.1. Overview 8.5.14.2. Financial performance 8.5.14.3. Product benchmarking 8.5.14.4. Strategic initiatives 8.5.15. Candelis Corporation 8.5.15.1. Overview 8.5.15.2. Financial performance 8.5.15.3. Product benchmarking 8.5.15.4. Strategic initiatives 8.5.16. Phoenix Ortho 8.5.16.1. Overview 8.5.16.2. Financial performance 8.5.16.3. Product benchmarking 8.5.16.4. Strategic initiatives List of Tables/GraphsList of TablesTable 1 List of abbreviations Table 2 List of secondary data sources Table 3 North America Specialty PACS market, by country, 2021 - 2033 (USD Million) Table 4 North America Specialty PACS market, by Specialty, 2021 - 2033 (USD Million) Table 5 North America Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million) Table 6 North America Specialty PACS market, by end use, 2021 - 2033 (USD Million) Table 7 US Specialty PACS market, by Specialty, 2021 - 2033 (USD Million) Table 8 US Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million) Table 9 US Specialty PACS market, by end use, 2021 - 2033 (USD Million) Table 10 Canada Specialty PACS market, by Specialty, 2021 - 2033 (USD Million) Table 11 Canada Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million) Table 12 Canada Specialty PACS market, by end use, 2021 - 2033 (USD Million) Table 13 Mexico Specialty PACS market, by Specialty, 2021 - 2033 (USD Million) Table 14 Mexico Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million) Table 15 Mexico Specialty PACS market, by end use, 2021 - 2033 (USD Million) Table 16 Europe Specialty PACS market, by country, 2021 - 2033 (USD Million) Table 17 Europe Specialty PACS market, by Specialty, 2021 - 2033 (USD Million) Table 18 Europe Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million) Table 19 Europe Specialty PACS market, by end use, 2021 - 2033 (USD Million) Table 20 Germany Specialty PACS market, by Specialty, 2021 - 2033 (USD Million) Table 21 Germany Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million) Table 22 Germany Specialty PACS market, by end use, 2021 - 2033 (USD Million) Table 23 UK Specialty PACS market, by Specialty, 2021 - 2033 (USD Million) Table 24 UK Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million) Table 25 UK Specialty PACS market, by end use, 2021 - 2033 (USD Million) Table 26 France Specialty PACS market, by Specialty, 2021 - 2033 (USD Million) Table 27 France Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million) Table 28 France Specialty PACS market, by end use, 2021 - 2033 (USD Million) Table 29 Italy Specialty PACS market, by Specialty, 2021 - 2033 (USD Million) Table 30 Italy Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million) Table 31 Italy Specialty PACS market, by end use, 2021 - 2033 (USD Million) Table 32 Spain Specialty PACS market, by Specialty, 2021 - 2033 (USD Million) Table 33 Spain Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million) Table 34 Spain Specialty PACS market, by end use, 2021 - 2033 (USD Million) Table 35 Sweden Specialty PACS market, by Specialty, 2021 - 2033 (USD Million) Table 36 Sweden Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million) Table 37 Sweden Specialty PACS market, by end use, 2021 - 2033 (USD Million) Table 38 Denmark Specialty PACS market, by Specialty, 2021 - 2033 (USD Million) Table 39 Denmark Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million) Table 40 Denmark Specialty PACS market, by end use, 2021 - 2033 (USD Million) Table 41 Norway Specialty PACS market, by Specialty, 2021 - 2033 (USD Million) Table 42 Norway Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million) Table 43 Norway Specialty PACS market, by end use, 2021 - 2033 (USD Million) Table 44 Asia Pacific Specialty PACS market, by country, 2021 - 2033 (USD Million) Table 45 Asia Pacific Specialty PACS market, by Specialty, 2021 - 2033 (USD Million) Table 46 Asia Pacific Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million) Table 47 Asia Pacific Specialty PACS market, by end use, 2021 - 2033 (USD Million) Table 48 China Specialty PACS market, by Specialty, 2021 - 2033 (USD Million) Table 49 China Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million) Table 50 China Specialty PACS market, by end use, 2021 - 2033 (USD Million) Table 51 Japan Specialty PACS market, by Specialty, 2021 - 2033 (USD Million) Table 52 Japan Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million) Table 53 Japan Specialty PACS market, by end use, 2021 - 2033 (USD Million) Table 54 India Specialty PACS market, by Specialty, 2021 - 2033 (USD Million) Table 55 India Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million) Table 56 India Specialty PACS market, by end use, 2021 - 2033 (USD Million) Table 57 Australia Specialty PACS market, by Specialty, 2021 - 2033 (USD Million) Table 58 Australia Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million) Table 59 Australia Specialty PACS market, by end use, 2021 - 2033 (USD Million) Table 60 Thailand Specialty PACS market, by Specialty, 2021 - 2033 (USD Million) Table 61 Thailand Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million) Table 62 Thailand Specialty PACS market, by end use, 2021 - 2033 (USD Million) Table 63 South Korea Specialty PACS market, by Specialty, 2021 - 2033 (USD Million) Table 64 South Korea Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million) Table 65 South Korea Specialty PACS market, by end use, 2021 - 2033 (USD Million) Table 66 Latin America Specialty PACS market, by country, 2021 - 2033 (USD Million) Table 67 Latin America Specialty PACS market, by Specialty, 2021 - 2033 (USD Million) Table 68 Latin America Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million) Table 69 Latin America Specialty PACS market, by end use, 2021 - 2033 (USD Million) Table 70 Brazil Specialty PACS market, by Specialty, 2021 - 2033 (USD Million) Table 71 Brazil Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million) Table 72 Brazil Specialty PACS market, by end use, 2021 - 2033 (USD Million) Table 73 Argentina Specialty PACS market, by Specialty, 2021 - 2033 (USD Million) Table 74 Argentina Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million) Table 75 Argentina Specialty PACS market, by end use, 2021 - 2033 (USD Million) Table 76 MEA Specialty PACS market, by country, 2021 - 2033 (USD Million) Table 77 MEA Specialty PACS market, by Specialty, 2021 - 2033 (USD Million) Table 78 MEA Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million) Table 79 MEA Specialty PACS market, by end use, 2021 - 2033 (USD Million) Table 80 South Africa Specialty PACS market, by Specialty, 2021 - 2033 (USD Million) Table 81 South Africa Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million) Table 82 South Africa Specialty PACS market, by end use, 2021 - 2033 (USD Million) Table 83 Saudi Arabia Specialty PACS market, by Specialty, 2021 - 2033 (USD Million) Table 84 Saudi Arabia Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million) Table 85 Saudi Arabia Specialty PACS market, by end use, 2021 - 2033 (USD Million) Table 86 UAE Specialty PACS market, by Specialty, 2021 - 2033 (USD Million) Table 87 UAE Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million) Table 88 UAE Specialty PACS market, by end use, 2021 - 2033 (USD Million) Table 89 Kuwait Specialty PACS market, by Specialty, 2021 - 2033 (USD Million) Table 90 Kuwait Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million) Table 91 Kuwait Specialty PACS market, by end use, 2021 - 2033 (USD Million)List of Figures Fig. 1 Market research process Fig. 2 Data triangulation techniques Fig. 3 Market formulation & validation Fig. 4 Specialty PACS market: Market outlook Fig. 5 Specialty PACS market: Segment outlook Fig. 6 Specialty PACS market: Competitive landscape outlook Fig. 7 Parent market outlook Fig. 8 Specialty PACS market Driver Impact Fig. 9 Specialty PACS market Restraint impact Fig. 10 Specialty PACS market, specialty outlook: Key takeaways, (USD Million) Fig. 11 Specialty PACS market: specialty movement analysis (USD Million) Fig. 12 Radiology PACS market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 13 Cardiology PACS market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 14 Mammography PACS market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 15 Orthopedic PACS market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 16 Ophthalmology PACS market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 17 Pathology PACS market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 18 Oncology / Radiation Therapy PACS market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 19 Others market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 20 Specialty PACS market, deployment mode outlook key takeaways (USD Million) Fig. 21 Specialty PACS market: deployment mode movement analysis (USD Million) Fig. 22 Cloud-Based/Web-Based market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 23 On-Premise market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 24 Hybrid market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 25 Specialty PACS market, end use outlook key takeaways (USD Million) Fig. 26 Specialty PACS market: end use movement analysis (USD Million) Fig. 27 Hospitals market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 28 Specialty Clinics market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 29 Diagnostic Imaging Centers market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 30 Telemedicine & Teleradiology Providers market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 31 Others market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 32 Regional marketplace: Key takeaways Fig. 33 Specialty PACS market: Regional outlook, 2024 & 2033 Fig. 34 North America Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 35 US Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 36 Canada Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 37 Mexico Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 38 Europe Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 39 UK Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 40 Germany Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 41 France Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 42 Italy Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 43 Spain Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 44 Denmark Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 45 Sweden Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 46 Norway Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 47 Asia Pacific Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 48 Japan Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 49 China Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 50 India Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 51 South Korea Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 52 Australia Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 53 Thailand Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 54 Latin America Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 55 Brazil Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 56 MEA Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 57 South Africa Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 58 Saudi Arabia Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 59 UAE Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million) Fig. 60 Kuwait Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療IT）の最新刊レポート
Grand View Research社の ヘルスケアIT分野 での最新刊レポート
本レポートと同じKEY WORD（communication）の最新刊レポート
よくあるご質問Grand View Research社はどのような調査会社ですか?グランドビューリサーチ（Grand View Research）は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
